Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have received a consensus rating of “Moderate Buy” from the twelve analysts that are currently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $10.50.

Several equities analysts have recently commented on the stock. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a report on Friday, March 20th. Barclays lowered their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Finally, Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th.

Aveanna Healthcare Trading Down 2.2%

NASDAQ AVAH opened at $7.17 on Friday. Aveanna Healthcare has a twelve month low of $3.73 and a twelve month high of $10.32. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The stock has a market cap of $1.56 billion, a price-to-earnings ratio of 6.08, a PEG ratio of 0.87 and a beta of 1.93. The firm’s 50 day moving average price is $6.79 and its two-hundred day moving average price is $7.79.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.92 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare’s revenue was up 15.9% on a year-over-year basis. Equities analysts anticipate that Aveanna Healthcare will post 0.56 EPS for the current year.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 125,000 shares of the company’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total value of $948,750.00. Following the completion of the sale, the insider directly owned 212,755 shares in the company, valued at approximately $1,614,810.45. This represents a 37.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of large investors have recently bought and sold shares of AVAH. AQR Capital Management LLC boosted its holdings in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after purchasing an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Aveanna Healthcare by 8.3% in the first quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after purchasing an additional 25,974 shares in the last quarter. Jane Street Group LLC boosted its holdings in Aveanna Healthcare by 522.0% in the first quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after purchasing an additional 63,010 shares in the last quarter. Creative Planning boosted its holdings in Aveanna Healthcare by 15.1% in the second quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after purchasing an additional 6,171 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Aveanna Healthcare by 65.0% in the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after purchasing an additional 62,348 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.